Therapy for relapsed/refractory disease needs to be made a decision dependant upon prior therapy as well as The explanation why the first remedy was now not acceptable (e.g., refractoriness vs. intolerance). Ibrutinib is the current gold typical therapy for individuals with relapsed/refractory disor